Ainsworth Sean
SEC CIK 1830296 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Dir | 321.7K | — | — | 7 | 2022-10-19 | 2026-04-20 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 16:26 | 2026-04-20 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | $0.00 | +24.4K | 321.7K | +8% | $0 | |
| 2026-01-05 | 2026-01-01 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | — | +42.5K | 297.3K | +17% | — | |
| 2025-08-27 | 2025-08-25 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | $1.15 | +87.0K | 254.8K | +52% | +$100.0K | |
| D | 2025-05-02 | 2025-04-30 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | $0.00 | +79.5K | 167.9K | +90% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | $0.00 | +41.1K | 88.4K | +87% | $0 |
| D | 2023-06-08 | 2023-06-06 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | A - Grant | $0.00 | +11.0K | 47.2K | +30% | $0 |
| D | 2022-10-20 | 2022-10-19 | IRD | Opus Genetics, Inc. | Ainsworth Sean | Dir | X - OptEx | $0.00 | +1,574 | 41.2K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations